Search Results - "Kravchenko, Sergey K."
-
1
Humoral Effect of a B-Cell Tumor on the Bone Marrow Multipotent Mesenchymal Stromal Cells
Published in Biochemistry (Moscow) (01-02-2021)“…The properties of bone marrow (BM)-derived multipotent mesenchymal stromal cells (MSCs) are altered in the patients with the diffuse large B cell lymphoma…”
Get full text
Journal Article -
2
А New Combination of Prognostic Markers in Follicular Lymphoma That Influences the Choice of Therapy
Published in Blood (23-11-2021)“…Background: Follicular lymphoma (FL) is characterized by clinical and morphological heterogeneity. It is based on the pathogenetic mechanisms of the…”
Get full text
Journal Article -
3
A Successful Experience with Brentuximab Vedotin in Relapsing/Refractory Cutaneous T-Cell Lymphoma: Two Case Reports
Published in Blood (29-11-2018)“…Primary cutaneous T-cell lymphomas are non-Hodgkin lymphomas of the skin defined by the presence of malignant T lymphocyte clonality. Mycosis fungoides (MF)…”
Get full text
Journal Article -
4
The Possibilities of Diffusion-Weighted Magnetic Resonance Imaging in Determining the Burden of a Tumor in Patients with Follicular Lymphoma
Published in Blood (13-11-2019)“…Follicular lymphoma (FL) is a B-cell tumor, which in most patients is characterized by slow growth and an “indolent” clinical course. In 80% of patients bone…”
Get full text
Journal Article -
5
A Single Institutional Experience of 49 Patients with Large Granular Lymphocytic Leukemia: Clinical and Immunophenotypic Characteristics and the Significance of Immune Therapy
Published in Blood (08-12-2017)“…T-cell large granular lymphocytic leukemia (LGL) is a rare type of T-cell lymphomas characterized by proliferation of clonal LGL (in the amount exceeding 0.5 x…”
Get full text
Journal Article -
6
Late Events in Adult Patients with ALK-Positive Anaplastic Large Cell Lymphoma
Published in Blood (08-12-2017)“…ALK-positive anaplastic large cell lymphoma is a lymphoproliferative disorder of “young age”; its incidence among all non-Hodgkin lymphomas in adult patient…”
Get full text
Journal Article -
7
Anaplastic Large-Cell Lymphomas in Adults: The Cytogenetic and Molecular Genetic Characteristics, Treatment Results (a single institutional experience)
Published in Blood (08-12-2017)“…Anaplastic large cell lymphomas in adults is a group of rare diseases that are characterized by aggressive clinical course, generalization of the process, high…”
Get full text
Journal Article -
8
Treatment of Relapsing/Refractory Hodgkin's Disease
Published in Blood (29-11-2018)“…Relapses of Hodgkin's disease (HD) occur in 10-15% of patients with a local tumor and in 20-40% of patients with advanced stages. A relapse of HD is early in…”
Get full text
Journal Article -
9
Alterations in Secretome and Transcriptome of Bone Marrow Derived MSCs in Patients with Diffuse Large B-Cell Lymphoma without Bone Marrow Involvement
Published in Blood (13-11-2019)“…Introduction Multipotent mesenchymal stromal cells (MSCs) differentiate into all mesenchymal lineages, regulate hematopoietic stem cells, and also take part in…”
Get full text
Journal Article -
10
Changes in the Multipotent Stromal Mesenchymal Cells from the Bone Marrow of the Patients with Hematological Diseases in Debut and after the Treatment
Published in Blood (13-11-2019)“…Introduction. Stromal microenvironment of the bone marrow (BM) is essential for normal hematopoiesis; the very same cells are involved in the interaction with…”
Get full text
Journal Article -
11
The Choice of Treatment for Elderly AML-Patients: 7+3 or Low Doses ARA-C
Published in Blood (13-11-2019)“…Background Acute myeloid leukemia (AML) in older adults is a biologically and clinically distinct entity. These patients often have comorbidities, and their…”
Get full text
Journal Article -
12
Extramediastinal Lesion in Patients with Primary Mediastinal Large B-Cell Lymphoma
Published in Blood (08-12-2017)“…Introduction. Primary mediastinal large B-cell lymphoma (PMBCL) is derived from a thymic B-cell and commonly presents as a bulky lesion in anterior-superior…”
Get full text
Journal Article -
13
Bone Marrow Involvement in Primary Mediastinal B-Cell Large-Cell Lymphoma
Published in Blood (08-12-2017)“…Introduction: Primary Mediastinal Large B-cell Lymphoma (PMBCL) is one of the primary extranodal lymphomas and originating from the thymic medulla B-cells…”
Get full text
Journal Article -
14
Alterations in the Properties of MSCs in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) without Bone Marrow Involvement
Published in Blood (29-11-2018)“…The stromal microenvironment regulating hematopoiesis in patients with hematologic malignancies undergoes significant alterations. The changes in the…”
Get full text
Journal Article -
15
Two Variants of Follicular Lymphoma Grade 3
Published in Blood (08-12-2017)“…Actuality: FL3 is a heterogeneous group of follicular lymphomas. Detailed morphological, immunophenotypic and genetic characteristics of FL3 allow to explain…”
Get full text
Journal Article -
16
Theraputic Approaches to High Grade B-Cell Lymphoma Double-Hit and Follicular Lymphoma with C -MYC, BCL2 and/or BCL6 rearrangements. Single Center Expirience
Published in Blood (08-12-2017)“…Introduction. An appearance of secondary c-MYC gene rearrangement in patients with follicular lymphoma (FL) can predispose to histologic transformation of FL…”
Get full text
Journal Article -
17
Rituximab-Bendamustine in First Line Treatment of Patients with Follicular Lymphoma. Results of Prospective Multicenter Study
Published in Blood (08-12-2017)“…BACKGROUND. Follicular lymphoma (FL) is lymphoid tumor that occurs in 22% of all non-Hodgkin's lymphomas (NHL) in Russia with median age 65 years. FL has a…”
Get full text
Journal Article -
18
Prognostic Role Of The Microenvironment In Follicular lymphoma
Published in Blood (15-11-2013)“…Follicular lymphoma (FL) is characterized by clinical heterogeneity. There is a need for easily quantifiable prognostic biomarkers. No consensus has been…”
Get full text
Journal Article -
19
Plasmapheresis Is an Effective Approach Preventing Clinically Significant Tumor Lysis Syndrome during Induction Therapy in AML Patients with Hyperleukocytosis
Published in Blood (06-12-2014)“…Introduction. Most studies have found that hyperleukocytosis (HL >100*109/l) is a poor prognostic factor in acute myeloid leukemia (AML). It is diagnosed in…”
Get full text
Journal Article -
20
Blood and Lymphatic Microenvironment As Prognostic Marker in Follicular Lymphoma
Published in Blood (16-11-2012)“…Abstract 2696 Follicular lymphoma (FL) has considerable clinical heterogeneity. There is a need for easily quantifiable prognostic biomarkers. There is no…”
Get full text
Journal Article